Aker Biomarine AS (AKBM) - Total Assets
Based on the latest financial reports, Aker Biomarine AS (AKBM) holds total assets worth Nkr387.00 Million NOK (≈ $40.72 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore AKBM operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Aker Biomarine AS - Total Assets Trend (2016–2024)
This chart illustrates how Aker Biomarine AS's total assets have evolved over time, based on quarterly financial data. See what is Aker Biomarine AS's book value for net asset value and shareholders' equity analysis.
Aker Biomarine AS - Asset Composition Analysis
Current Asset Composition (December 2024)
Aker Biomarine AS's total assets of Nkr387.00 Million consist of 52.1% current assets and 47.9% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr15.00 Million | 3.7% |
| Accounts Receivable | Nkr47.30 Million | 12.2% |
| Inventory | Nkr96.30 Million | 24.9% |
| Property, Plant & Equipment | Nkr51.60 Million | 13.3% |
| Intangible Assets | Nkr60.80 Million | 15.7% |
| Goodwill | Nkr62.60 Million | 16.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how Aker Biomarine AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see AKBM stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aker Biomarine AS's current assets represent 52.1% of total assets in 2024, an increase from 24.4% in 2016.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, up from 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 23.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 24.9% of total assets.
Aker Biomarine AS Competitors by Total Assets
Key competitors of Aker Biomarine AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
The Magnum Ice Cream Company N.V.
AS:MICC
|
Netherlands | €7.49 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Premium Brands Holdings Corporation
TO:PBH
|
Canada | CA$7.34 Billion |
|
Unibel S.A
PA:UNBL
|
France | €4.09 Billion |
|
Bikaji Foods International Limited
NSE:BIKAJI
|
India | Rs22.40 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.03 Billion |
Aker Biomarine AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.62 | 1.97 | 3.20 |
| Quick Ratio | 1.25 | 1.58 | 1.37 |
| Cash Ratio | 0.26 | 0.00 | 0.16 |
| Working Capital | Nkr120.40 Million | Nkr277.00 Million | Nkr170.04 Million |
Aker Biomarine AS - Advanced Valuation Insights
This section examines the relationship between Aker Biomarine AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.69 |
| Latest Market Cap to Assets Ratio | 2.68 |
| Asset Growth Rate (YoY) | -53.2% |
| Total Assets | Nkr387.40 Million |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Aker Biomarine AS's assets at a significant premium (2.68x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Aker Biomarine AS's assets decreased by 53.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aker Biomarine AS (2016–2024)
The table below shows the annual total assets of Aker Biomarine AS from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr387.40 Million ≈ $40.77 Million |
-53.16% |
| 2023-12-31 | Nkr827.10 Million ≈ $87.03 Million |
+0.32% |
| 2022-12-31 | Nkr824.50 Million ≈ $86.76 Million |
+8.85% |
| 2021-12-31 | Nkr757.49 Million ≈ $79.71 Million |
+8.15% |
| 2020-12-31 | Nkr700.43 Million ≈ $73.71 Million |
+1.19% |
| 2019-12-31 | Nkr692.22 Million ≈ $72.84 Million |
+60.89% |
| 2018-12-31 | Nkr430.25 Million ≈ $45.27 Million |
+14.00% |
| 2017-12-31 | Nkr377.41 Million ≈ $39.71 Million |
+35.11% |
| 2016-12-31 | Nkr279.34 Million ≈ $29.39 Million |
-- |
About Aker Biomarine AS
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LY… Read more